Skip to search formSkip to main contentSkip to account menu

LC16M8

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis.
2018
2018
Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8
LC16m8 (m8), a highly attenuated vaccinia virus (VAC) strain, was developed as a smallpox vaccine, and its safety and… 
Review
2014
Review
2014
Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications
The LC16m8 strain of vaccinia virus, the active ingredient in the Japanese smallpox vaccine, was derived from the Lister/Elstree… 
2014
2014
Glycosylated and Nonglycosylated Complement Control Protein of the Lister Strain of Vaccinia Virus
ABSTRACT The vaccinia virus complement control protein (VCP) is a secreted viral protein that binds the C3b and C4b complement… 
2012
2012
Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults.
Highly Cited
2009
Highly Cited
2009
Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
CONTEXT The attenuated, tissue-cultured, third-generation smallpox vaccine LC16m8 was administered to vaccinia-naive infants in… 
2009
2009
Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model
ABSTRACT The immune response elicited by LC16m8, a candidate smallpox vaccine that was developed in Japan by cold selection… 
2009
2009
Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC 16 m 8
THE THREAT OF SMALLPOX BIOterrorism has prompted reconsideration of the need for smallpox vaccination. Serious adverse events… 
2008
2008
Post-Exposure Vaccination with a Highly Attenuated Vaccinia Vaccine, LC16m8, for Protection of Nonhuman Primates from Monkeypox
2004
2004
Smallpox vaccine LC16m8 protects against in vivo challenge
  • 2004
  • Corpus ID: 195138274
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)